Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Million Dollar Molecule

<< Previous

Bullboard Posts

Next >>

Comment by Finnexason Oct 24, 2022 4:38pm

142 Views

Post# 35044887

RE:RE:RE:RE:Million Dollar Molecule

Most people don't have a clue how significant this is. Go research C60 and fullerenes. The health benefits and applications are amazing. It has been so expensive that it has not been able to be utilized in most applications. This will potentially solve that for all uses. People love spouting off with out knowing facts or understand how much work and time it takes tomdo these things. Typical social media BS.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant